Want to see FR:VETO full AI Analyst Report?
VETO Stock Chart & Stats
€84.40
€0.20(0.26%)
At close: 4:00 PM EST
€84.40
€0.20(0.26%)
Day’s Range― - ―
52-Week Range€67.20 - €91.50
Previous CloseN/A
Volume18.00
Average Volume (3M)5.40K
Market Cap
€838.47M
Enterprise Value€591.66M
Total Cash (Recent Filing)€221.08M
Total Debt (Recent Filing)€15.29M
Price to Earnings (P/E)14.7
Beta0.41
Next Earnings
Sep 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.06%
Share Statistics
EPS (TTM)4.82
Shares Outstanding11,881,902
10 Day Avg. Volume4,099
30 Day Avg. Volume5,401
Financial Highlights & Ratios
PEG Ratio-21.04
Price to Book (P/B)1.68
Price to Sales (P/S)1.89
P/FCF Ratio19.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5.28
Revenue Forecast (FY)€525.77M
Bulls Say, Bears Say
Bulls Say
Earnings GrowthVetoquinol's adjusted EBIT has returned to growth for the first time in 3 years, marking the start of a positive upturn.
Financial PerformanceThe company's high gross margin and strong financial resources are expected to accelerate EPS growth.
Bears Say
Potential DelistingThe group has a net cash position of at least €150m, representing firepower of €450m, which may incentivize the majority shareholder to attempt to delist the company if the strong discount persists.
VETOQUINOL News
VETO FAQ
What was VETOQUINOL’s price range in the past 12 months?
VETOQUINOL lowest stock price was €67.20 and its highest was €91.50 in the past 12 months.
What is VETOQUINOL’s market cap?
VETOQUINOL’s market cap is €838.47M.
When is VETOQUINOL’s upcoming earnings report date?
VETOQUINOL’s upcoming earnings report date is Sep 11, 2026 which is in 71 days.
How were VETOQUINOL’s earnings last quarter?
VETOQUINOL released its earnings results on Mar 27, 2026. The company reported €2.778 earnings per share for the quarter, beating the consensus estimate of N/A by €2.778.
Is VETOQUINOL overvalued?
According to Wall Street analysts VETOQUINOL’s price is currently Overvalued.
Does VETOQUINOL pay dividends?
VETOQUINOL pays a Annually dividend of €0.93 which represents an annual dividend yield of 1.06%. See more information on VETOQUINOL dividends here
What is VETOQUINOL’s EPS estimate?
VETOQUINOL’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VETOQUINOL have?
VETOQUINOL has 11,881,902 shares outstanding.
What happened to VETOQUINOL’s price movement after its last earnings report?
VETOQUINOL reported an EPS of €2.778 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.984%.
Which hedge fund is a major shareholder of VETOQUINOL?
Currently, no hedge funds are holding shares in FR:VETO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VETOQUINOL
Vetoquinol S.A. is a prominent veterinary pharmaceutical enterprise dedicated to the innovation, development, and global commercialization of both medicinal and non-medicinal solutions for animal health. Its operations extend across Europe, the Americas, and the Asia Pacific regions. The company's diverse product portfolio addresses crucial therapeutic areas, including mobility, pain management, and inflammation; dermatological care and hygiene; anti-parasitic treatments; udder health; infectious disease control; reproductive solutions; behavior modification; internal medicine; and cardiovascular-renal support. These offerings cater to a wide spectrum of animals, encompassing livestock such as cattle, sheep, pigs, and poultry, alongside companion animals like dogs. Founded in 1933, Vetoquinol S.A. is headquartered in Lure, France, and functions as a subsidiary of Soparfin SCA.
Technical Analysis
Options Prices
Currently, No data available
---